Henri Mondor Hospital
Créteil, 94010, France
NCT Number: NCT02539771
Hypothesis is that the occurrence of nocturnal Vaso-Occlusive Crisis (VOC) and priapism in adults might be related to episodes of nocturnal desaturation secondary to a sleep apnea syndrome. Investigator hypothesize that chronic biological consequences of Obstructive Sleep Apnea (hypercoagulability, endothelial dysfunction ...) favour VOC and acute manifestations (nocturnal desaturation) favour nocturnal VOC.
The confirmation of this hypothesis will lead investigator to propose a systematic screening of obstructive sleep apnea (OSA) in patients with nocturnal VOC. Moreover, systematic treatment of OSA in sickle cell patients could help significantly reduce the number and severity of nocturnal VOC.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Créteil, 94010, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Night VOC Group:
Daytime VOC Group:
Slightly symptomatic group:
Exclusion criteria
Blood collection is a specific intervention of protocol for the 3 arms. Polysomnography is a specific intervention for the arms " Diurnal VOC " and " Slightly symptomatic "
Time frame: at 1 year
Time frame: at 1 year
Time frame: at 1 year
Time frame: at 1 year
Time frame: at 1 year
Time frame: at 1 year
Time frame: at 1 year
Time frame: at 1 year
Assistance Publique - Hôpitaux de Paris
Other
Acronym: DREPASOM
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05780775
Anemia, Anemia, Hemolytic
Pointe-à-Pitre, Guadeloupe
View Trial DetailsNCT05407805
Anemia, Anemia, Hemolytic
Hollywood, Florida, United States
View Trial DetailsNCT01891812
Anemia, Anemia, Hemolytic
New York, United States
View Trial DetailsNCT04987489
Anemia, Anemia, Hemolytic
Cerritos, California, United States
View Trial Details